 |
PDBsum entry 4tnx
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Structure basis of cellular dntp regulation, samhd1-gtp-dgtp complex
|
|
Structure:
|
 |
Deoxynucleoside triphosphate triphosphohydrolase samhd1. Chain: a, b, c, d. Fragment: unp residues 113-626. Synonym: dntpase,dendritic cell-derived ifng-induced protein,dcip, monocyte protein 5,mop-5,sam domain and hd domain-containing protein 1. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: samhd1, mop5. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
2.31Å
|
R-factor:
|
0.190
|
R-free:
|
0.226
|
|
|
Authors:
|
 |
X.Ji,C.Tang,Q.Zhao,W.Wang,Y.Xiong
|
|
Key ref:
|
 |
X.Ji
et al.
(2014).
Structural basis of cellular dNTP regulation by SAMHD1.
Proc Natl Acad Sci U S A,
111,
E4305.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
05-Jun-14
|
Release date:
|
01-Oct-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9Y3Z3
(SAMH1_HUMAN) -
Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
626 a.a.
481 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
111:E4305
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis of cellular dNTP regulation by SAMHD1.
|
|
X.Ji,
C.Tang,
Q.Zhao,
W.Wang,
Y.Xiong.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The sterile alpha motif and HD domain-containing protein 1 (SAMHD1), a dNTPase,
prevents the infection of nondividing cells by retroviruses, including HIV, by
depleting the cellular dNTP pool available for viral reverse transcription.
SAMHD1 is a major regulator of cellular dNTP levels in mammalian cells.
Mutations in SAMHD1 are associated with chronic lymphocytic leukemia (CLL) and
the autoimmune condition Aicardi Goutières syndrome (AGS). The dNTPase activity
of SAMHD1 can be regulated by dGTP, with which SAMHD1 assembles into
catalytically active tetramers. Here we present extensive biochemical and
structural data that reveal an exquisite activation mechanism of SAMHD1 via
combined action of both GTP and dNTPs. We obtained 26 crystal structures of
SAMHD1 in complex with different combinations of GTP and dNTP mixtures, which
depict the full spectrum of GTP/dNTP binding at the eight allosteric and four
catalytic sites of the SAMHD1 tetramer. Our data demonstrate how SAMHD1 is
activated by binding of GTP or dGTP at allosteric site 1 and a dNTP of any type
at allosteric site 2. Our enzymatic assays further reveal a robust regulatory
mechanism of SAMHD1 activity, which bares resemblance to that of the
ribonuclease reductase responsible for cellular dNTP production. These results
establish a complete framework for a mechanistic understanding of the important
functions of SAMHD1 in the regulation of cellular dNTP levels, as well as in HIV
restriction and the pathogenesis of CLL and AGS.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |